Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 491

1.

A human case of spotted fever caused by Rickettsia parkeri strain Atlantic rainforest and its association to the tick Amblyomma ovale.

da Paixão Sevá A, Martins TF, Muñoz-Leal S, Rodrigues AC, Pinter A, Luz HR, Angerami RN, Labruna MB.

Parasit Vectors. 2019 Oct 11;12(1):471. doi: 10.1186/s13071-019-3730-2.

PMID:
31604442
2.

Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients.

Gerdes S, Pinter A, Papavassilis C, Reinhardt M.

J Eur Acad Dermatol Venereol. 2019 Oct 10. doi: 10.1111/jdv.16004. [Epub ahead of print]

PMID:
31599476
3.

Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus.

Silverberg JI, Pinter A, Pulka G, Poulin Y, Bouaziz JD, Wollenberg A, Murrell DF, Alexis A, Lindsey L, Ahmad F, Piketty C, Clucas A.

J Allergy Clin Immunol. 2019 Aug 23. pii: S0091-6749(19)31099-1. doi: 10.1016/j.jaci.2019.08.013. [Epub ahead of print]

4.

Autonomic Dysfunction in Preeclampsia: A Systematic Review.

Yousif D, Bellos I, Penzlin AI, Hijazi MM, Illigens BM, Pinter A, Siepmann T.

Front Neurol. 2019 Aug 6;10:816. doi: 10.3389/fneur.2019.00816. eCollection 2019.

5.

Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study.

Thaçi D, Puig L, Reich K, Tsai TF, Tyring S, Kingo K, Ziv M, Pinter A, Vender R, Lacombe A, Xia S, Bhosekar V, Gilloteau I, Guana A, Blauvelt A.

J Am Acad Dermatol. 2019 Aug 6. pii: S0190-9622(19)30640-1. doi: 10.1016/j.jaad.2019.04.045. [Epub ahead of print] No abstract available.

6.

A 24-week multicentre, randomised, open-label, parallel-group study comparing the efficacy and safety of ixekizumab to fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment.

Reich K, Augustin M, Thaçi D, Pinter A, Leutz A, Henneges C, Schneider E, Schacht A, Dossenbach M, Mrowietz U.

Br J Dermatol. 2019 Aug 3. doi: 10.1111/bjd.18384. [Epub ahead of print]

PMID:
31376153
7.

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review.

Pinter A, Bonnekoh B, Hadshiew IM, Zimmer S.

Clin Cosmet Investig Dermatol. 2019 Jul 10;12:509-517. doi: 10.2147/CCID.S211938. eCollection 2019.

8.

Epidermal expression of human TRPM8, but not of TRPA1 ion channels, is associated with sensory responses to local skin cooling.

Weyer-Menkhoff I, Pinter A, Schlierbach H, Schänzer A, Lötsch J.

Pain. 2019 Aug 14. doi: 10.1097/j.pain.0000000000001660. [Epub ahead of print]

PMID:
31343541
9.

ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients.

Schwarz PEH, Pinter A, Melzer N, Barteczek P, Reinhardt M.

Dermatol Ther (Heidelb). 2019 Sep;9(3):579-587. doi: 10.1007/s13555-019-0314-1. Epub 2019 Jul 11.

10.

Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis.

Pinter A, Gerdes S, Papavassilis C, Reinhardt M.

J Dermatolog Treat. 2019 Jul 16:1-7. doi: 10.1080/09546634.2019.1626973. [Epub ahead of print]

PMID:
31287332
11.

An Advanced In Silico Modelling of the Interaction between FSCPX, an Irreversible A1 Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium.

Szabo AM, Erdei T, Viczjan G, Kiss R, Zsuga J, Papp C, Pinter A, Juhasz B, Szilvassy Z, Gesztelyi R.

Molecules. 2019 Jun 12;24(12). pii: E2207. doi: 10.3390/molecules24122207.

12.

Cardiac dysautonomia in depression - heart rate variability biofeedback as a potential add-on therapy.

Pinter A, Szatmari S Jr, Horvath T, Penzlin AI, Barlinn K, Siepmann M, Siepmann T.

Neuropsychiatr Dis Treat. 2019 May 17;15:1287-1310. doi: 10.2147/NDT.S200360. eCollection 2019. Review.

13.

Adiponectin levels in a large pooled plaque psoriasis study population.

Gerdes S, Pinter A, Biermann M, Papavassilis C, Reinhardt M.

J Dermatolog Treat. 2019 Jun 9:1-4. doi: 10.1080/09546634.2019.1621979. [Epub ahead of print]

PMID:
31179792
14.

Quantification of abnormal QRS peaks predicts response to cardiac resynchronization therapy and tracks structural remodeling.

Suszko AM, Nayyar S, Porta-Sanchez A, Das M, Pinter A, Crystal E, Tomlinson G, Dalvi R, Chauhan VS.

PLoS One. 2019 Jun 6;14(6):e0217875. doi: 10.1371/journal.pone.0217875. eCollection 2019.

15.

Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study.

Broger T, Sossen B, du Toit E, Kerkhoff AD, Schutz C, Ivanova Reipold E, Ward A, Barr DA, Macé A, Trollip A, Burton R, Ongarello S, Pinter A, Lowary TL, Boehme C, Nicol MP, Meintjes G, Denkinger CM.

Lancet Infect Dis. 2019 Aug;19(8):852-861. doi: 10.1016/S1473-3099(19)30001-5. Epub 2019 May 30.

16.

Secretagogin expression in the vertebrate brainstem with focus on the noradrenergic system and implications for Alzheimer's disease.

Zahola P, Hanics J, Pintér A, Máté Z, Gáspárdy A, Hevesi Z, Echevarria D, Adori C, Barde S, Törőcsik B, Erdélyi F, Szabó G, Wagner L, Kovacs GG, Hökfelt T, Harkany T, Alpár A.

Brain Struct Funct. 2019 Jul;224(6):2061-2078. doi: 10.1007/s00429-019-01886-w. Epub 2019 May 29.

17.

Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study.

Thaçi D, Papp K, Marcoux D, Weibel L, Pinter A, Ghislain PD, Landells I, Hoeger PH, Unnebrink K, Seyger MMB, Williams DA, Rubant S, Philipp S.

Br J Dermatol. 2019 Apr 24. doi: 10.1111/bjd.18029. [Epub ahead of print]

PMID:
31017657
18.

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients.

Broger T, Tsionksy M, Mathew A, Lowary TL, Pinter A, Plisova T, Bartlett D, Barbero S, Denkinger CM, Moreau E, Katsuragi K, Kawasaki M, Nahid P, Sigal GB.

PLoS One. 2019 Apr 18;14(4):e0215443. doi: 10.1371/journal.pone.0215443. eCollection 2019.

19.

Continued treatment with secukinumab is associated with high retention or regain of response.

Augustin M, Thaci D, Eyerich K, Pinter A, Radtke M, Lauffer F, Mrowietz U, Gerdes S, Pariser D, Lebwohl M, Sieder C, Melzer N, Reich K.

Br J Dermatol. 2019 Apr 10. doi: 10.1111/bjd.17991. [Epub ahead of print]

PMID:
30972746
20.

Tolerability and Efficacy of a Medical Device Repairing Emollient Cream in Children and Adults with Mild to Moderate Atopic Dermatitis.

Pinter A, Thouvenin MD, Bacquey A, Rossi AB, Nocera T.

Dermatol Ther (Heidelb). 2019 Jun;9(2):309-319. doi: 10.1007/s13555-019-0295-0. Epub 2019 Apr 9.

21.

[Gastrointestinal side effects of apremilast : Characterization and management].

Pinter A, Beigel F, Körber A, Homey B, Beissert S, Gerdes S, Staubach-Renz P, Radtke MA, Mössner R.

Hautarzt. 2019 May;70(5):354-362. doi: 10.1007/s00105-019-4396-6. Review. German.

PMID:
30937481
22.

Topische Therapie bei Psoriasis vulgaris - ein Behandlungspfad.

Körber A, Wilsmann-Theis D, Augustin M, von Kiedrowski R, Mrowietz U, Rosenbach T, Meller S, Pinter A, Sticherling M, Gerdes S; PsoNet Förderverein.

J Dtsch Dermatol Ges. 2019 May;17 Suppl 4:3-14. doi: 10.1111/ddg.13810. Epub 2019 Mar 18.

PMID:
30883011
23.

A high gene flow in populations of Amblyomma ovale ticks found in distinct fragments of Brazilian Atlantic rainforest.

Fournier GFSR, Pinter A, Santiago R, Muñoz-Leal S, Martins TF, Lopes MG, McCoy KD, Toty C, Horta MC, Labruna MB, Dias RA.

Exp Appl Acarol. 2019 Feb;77(2):215-228. doi: 10.1007/s10493-019-00350-y. Epub 2019 Feb 25.

PMID:
30805817
24.

Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial.

Blauvelt A, Lomaga M, Burge R, Zhu B, Shen W, Shrom D, Dossenbach M, Pinter A.

J Dermatolog Treat. 2019 Feb 25:1-6. doi: 10.1080/09546634.2019.1587146. [Epub ahead of print]

PMID:
30799638
25.

Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases.

Pinter A, Wilsmann-Theis D, Peitsch WK, Mössner R.

J Dermatol. 2019 May;46(5):426-430. doi: 10.1111/1346-8138.14815. Epub 2019 Feb 20.

PMID:
30786053
26.

Unexpected High Prevalence of Cardiovascular Disease Risk Factors and Psychiatric Disease Among Young People With Sudden Cardiac Arrest.

Allan KS, Morrison LJ, Pinter A, Tu JV, Dorian P; Rescu Investigators.

J Am Heart Assoc. 2019 Jan 22;8(2):e010330. doi: 10.1161/JAHA.118.010330.

27.

Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey.

Mohr P, Haferkamp S, Pinter A, Weishaupt C, Huber MA, Downey G, Öhrling K, Loquai C, Louie KS.

Adv Ther. 2019 Jan;36(1):101-117. doi: 10.1007/s12325-018-0850-6. Epub 2018 Dec 7.

28.

Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks.

von Stebut E, Reich K, Thaçi D, Koenig W, Pinter A, Körber A, Rassaf T, Waisman A, Mani V, Yates D, Frueh J, Sieder C, Melzer N, Mehta NN, Gori T.

J Invest Dermatol. 2019 May;139(5):1054-1062. doi: 10.1016/j.jid.2018.10.042. Epub 2018 Nov 30.

29.

Text Mining Mental Health Reports for Issues Impacting Today's College Students: Qualitative Study.

Payton FC, Yarger LK, Pinter AT.

JMIR Ment Health. 2018 Oct 23;5(4):e10032. doi: 10.2196/10032.

30.

Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature.

Pinter A, Thormann H, Angeletti F, Jalili A.

Clin Cosmet Investig Dermatol. 2018 Oct 9;11:451-459. doi: 10.2147/CCID.S180698. eCollection 2018.

31.

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.

Sigal GB, Pinter A, Lowary TL, Kawasaki M, Li A, Mathew A, Tsionsky M, Zheng RB, Plisova T, Shen K, Katsuragi K, Choudhary A, Honnen WJ, Nahid P, Denkinger CM, Broger T.

J Clin Microbiol. 2018 Nov 27;56(12). pii: e01338-18. doi: 10.1128/JCM.01338-18. Print 2018 Dec.

32.

Hidradenitis Suppurativa After Radical Surgery-Long-Term Follow-up for Recurrences and Associated Factors.

Walter AC, Meissner M, Kaufmann R, Valesky E, Pinter A.

Dermatol Surg. 2018 Oct;44(10):1323-1331. doi: 10.1097/DSS.0000000000001668.

PMID:
30204742
33.

FSCPX, a Chemical Widely Used as an Irreversible A₁ Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium.

Erdei T, Szabo AM, Lampe N, Szabo K, Kiss R, Zsuga J, Papp C, Pinter A, Szentmiklosi AJ, Szilvassy Z, Juhasz B, Gesztelyi R.

Molecules. 2018 Aug 30;23(9). pii: E2186. doi: 10.3390/molecules23092186.

34.

Detection of lipoarabinomannan in urine and serum of HIV-positive and HIV-negative TB suspects using an improved capture-enzyme linked immuno absorbent assay and gas chromatography/mass spectrometry.

Amin AG, De P, Spencer JS, Brennan PJ, Daum J, Andre BG, Joe M, Bai Y, Laurentius L, Porter MD, Honnen WJ, Choudhary A, Lowary TL, Pinter A, Chatterjee D.

Tuberculosis (Edinb). 2018 Jul;111:178-187. doi: 10.1016/j.tube.2018.06.004. Epub 2018 Jun 6.

PMID:
30029905
35.

Option pricing in the moderate deviations regime.

Friz P, Gerhold S, Pinter A.

Math Financ. 2018 Jul;28(3):962-988. doi: 10.1111/mafi.12156. Epub 2017 Aug 25.

36.

Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of Mycobacterium tuberculosis, and Complexity of Antibody Specificities toward This Antigen.

Choudhary A, Patel D, Honnen W, Lai Z, Prattipati RS, Zheng RB, Hsueh YC, Gennaro ML, Lardizabal A, Restrepo BI, Garcia-Viveros M, Joe M, Bai Y, Shen K, Sahloul K, Spencer JS, Chatterjee D, Broger T, Lowary TL, Pinter A.

J Immunol. 2018 May 1;200(9):3053-3066. doi: 10.4049/jimmunol.1701673. Epub 2018 Apr 2.

37.

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.

Yates NL, deCamp AC, Korber BT, Liao HX, Irene C, Pinter A, Peacock J, Harris LJ, Sawant S, Hraber P, Shen X, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Berman PW, Robb ML, Pantaleo G, Zolla-Pazner S, Haynes BF, Alam SM, Montefiori DC, Tomaras GD.

J Virol. 2018 Mar 28;92(8). pii: e01843-17. doi: 10.1128/JVI.01843-17. Print 2018 Apr 15.

38.

Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.

Qualls ZM, Choudhary A, Honnen W, Prattipati R, Robinson JE, Pinter A.

J Virol. 2018 Feb 12;92(5). pii: e01779-17. doi: 10.1128/JVI.01779-17. Print 2018 Mar 1.

39.

Experimental infection of Rickettsia parkeri in the Rhipicephalus microplus tick.

Cordeiro MD, de Azevedo Baêta B, Cepeda PB, Teixeira RC, Ribeiro CCDU, de Almeida Valim JR, Pinter A, da Fonseca AH.

Ticks Tick Borne Dis. 2018 Jan;9(1):93-96. doi: 10.1016/j.ttbdis.2017.10.003. Epub 2017 Oct 7.

PMID:
29102467
40.

Centralization of Pediatric Surgery in Hungary.

Pintér A, Vajda P.

Eur J Pediatr Surg. 2017 Oct;27(5):429-430. doi: 10.1055/s-0037-1606838. Epub 2017 Sep 14. Review. No abstract available.

PMID:
28910832
41.

Automated Quantification of Low-Amplitude Abnormal QRS Peaks From High-Resolution ECG Recordings Predicts Arrhythmic Events in Patients With Cardiomyopathy.

Das M, Suszko AM, Nayyar S, Viswanathan K, Spears DA, Tomlinson G, Pinter A, Crystal E, Dalvi R, Krishnan S, Chauhan VS.

Circ Arrhythm Electrophysiol. 2017 Jul;10(7). pii: e004874. doi: 10.1161/CIRCEP.116.004874.

PMID:
28705874
42.

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.

Perez LG, Martinez DR, deCamp AC, Pinter A, Berman PW, Francis D, Sinangil F, Lee C, Greene K, Gao H, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Tartaglia J, O'Connell RJ, Robb ML, Michael NL, Kim JH, Gilbert P, Montefiori DC.

PLoS One. 2017 Jul 5;12(7):e0180720. doi: 10.1371/journal.pone.0180720. eCollection 2017.

43.

Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy.

Nabi R, Moldoveanu Z, Wei Q, Golub ET, Durkin HG, Greenblatt RM, Herold BC, Nowicki MJ, Kassaye S, Cho MW, Pinter A, Landay AL, Mestecky J, Kozlowski PA.

PLoS One. 2017 Jul 3;12(7):e0180245. doi: 10.1371/journal.pone.0180245. eCollection 2017.

44.

Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.

Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak Ł, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R; European Hidradenitis Suppurativa Foundation Investigator Group.

Br J Dermatol. 2017 Nov;177(5):1401-1409. doi: 10.1111/bjd.15748. Epub 2017 Oct 30.

PMID:
28636793
45.

Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Disease (CAPTURE PD): Protocol for a Multicenter Study.

Siepmann T, Pintér A, Buchmann SJ, Stibal L, Arndt M, Kubasch AS, Kubasch ML, Penzlin AI, Frenz E, Zago W, Horváth T, Szatmári S Jr, Bereczki D, Takáts A, Ziemssen T, Lipp A, Freeman R, Reichmann H, Barlinn K, Illigens BM.

Front Neurol. 2017 May 26;8:212. doi: 10.3389/fneur.2017.00212. eCollection 2017.

46.

"Presumed cardiac" arrest in children and young adults: A misnomer?

Allan KS, Morrison LJ, Pinter A, Tu JV, Dorian P; Rescu Epistry Investigators.

Resuscitation. 2017 Aug;117:73-79. doi: 10.1016/j.resuscitation.2017.06.003. Epub 2017 Jun 7.

PMID:
28602695
47.

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

Bradley T, Pollara J, Santra S, Vandergrift N, Pittala S, Bailey-Kellogg C, Shen X, Parks R, Goodman D, Eaton A, Balachandran H, Mach LV, Saunders KO, Weiner JA, Scearce R, Sutherland LL, Phogat S, Tartaglia J, Reed SG, Hu SL, Theis JF, Pinter A, Montefiori DC, Kepler TB, Peachman KK, Rao M, Michael NL, Suscovich TJ, Alter G, Ackerman ME, Moody MA, Liao HX, Tomaras G, Ferrari G, Korber BT, Haynes BF.

Nat Commun. 2017 Jun 8;8:15711. doi: 10.1038/ncomms15711.

48.

Evaluating the older adult experience of a web-based, tablet-delivered heart failure self-care program using gerontechnology principles.

Buck H, Pinter A, Poole E, Boehmer J, Foy A, Black S, Lloyd T.

Geriatr Nurs. 2017 Nov - Dec;38(6):537-541. doi: 10.1016/j.gerinurse.2017.04.001. Epub 2017 May 26.

PMID:
28554497
49.

Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study.

Reich K, Pinter A, Lacour JP, Ferrandiz C, Micali G, French LE, Lomaga M, Dutronc Y, Henneges C, Wilhelm S, Hartz S, Paul C; IXORA-S investigators.

Br J Dermatol. 2017 Oct;177(4):1014-1023. doi: 10.1111/bjd.15666. Epub 2017 Jul 19.

PMID:
28542874
50.

Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life.

Zsuga J, Erdei T, Szabó K, Lampe N, Papp C, Pinter A, Szentmiklosi AJ, Juhasz B, Szilvássy Z, Gesztelyi R.

Molecules. 2017 May 19;22(5). pii: E839. doi: 10.3390/molecules22050839.

Supplemental Content

Loading ...
Support Center